The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment
Само за регистроване кориснике
2014
Аутори
Kovač, MirjanaPruner, Iva
Kovac, Z.
Tomasević, Z.
Nesković-Konstantinović, Z.
Đorđević, Valentina
Radojković, Dragica
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
Thrombosis Research, 2014, 133, S103-S103Издавач:
- Pergamon-Elsevier Science Ltd, Oxford
Институција/група
Institut za molekularnu genetiku i genetičko inženjerstvoTY - CONF AU - Kovač, Mirjana AU - Pruner, Iva AU - Kovac, Z. AU - Tomasević, Z. AU - Nesković-Konstantinović, Z. AU - Đorđević, Valentina AU - Radojković, Dragica PY - 2014 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/711 PB - Pergamon-Elsevier Science Ltd, Oxford C3 - Thrombosis Research T1 - The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment EP - S103 SP - S103 VL - 133 DO - 10.1016/S0049-3848(14)50326-X ER -
@conference{ author = "Kovač, Mirjana and Pruner, Iva and Kovac, Z. and Tomasević, Z. and Nesković-Konstantinović, Z. and Đorđević, Valentina and Radojković, Dragica", year = "2014", publisher = "Pergamon-Elsevier Science Ltd, Oxford", journal = "Thrombosis Research", title = "The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment", pages = "S103-S103", volume = "133", doi = "10.1016/S0049-3848(14)50326-X" }
Kovač, M., Pruner, I., Kovac, Z., Tomasević, Z., Nesković-Konstantinović, Z., Đorđević, V.,& Radojković, D.. (2014). The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment. in Thrombosis Research Pergamon-Elsevier Science Ltd, Oxford., 133, S103-S103. https://doi.org/10.1016/S0049-3848(14)50326-X
Kovač M, Pruner I, Kovac Z, Tomasević Z, Nesković-Konstantinović Z, Đorđević V, Radojković D. The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment. in Thrombosis Research. 2014;133:S103-S103. doi:10.1016/S0049-3848(14)50326-X .
Kovač, Mirjana, Pruner, Iva, Kovac, Z., Tomasević, Z., Nesković-Konstantinović, Z., Đorđević, Valentina, Radojković, Dragica, "The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment" in Thrombosis Research, 133 (2014):S103-S103, https://doi.org/10.1016/S0049-3848(14)50326-X . .